Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Praziquantel Pharmaceutical Secondary Standard, MilliporeSigma™ Supelco™
Click to view available options
Quantity:
1 g
Description
Praziquantel is at present the only drug used for the treatment of human schistosomiasis. It has a pyrazino isoquinoline ring system and is found to be very successful in animals for its anticestode and antitrematode properties. It has been identified that the voltage-gated schistosome calcium ion (Ca2+) channels serve as a target for praziquantel. Even though the commercial preparation of praziquantel comprises of equal amounts of both its 'dextro′ and 'laevo′ isomers, only the 'laevo′ form exhibits schistosomicidal activity.Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Specifications
Specifications
CAS | 55268-74-1 |
Physical Form | Neat |
Linear Formula | C19H24N2O2 |
MDL Number | MFCD00058531 |
Synonym | Praziquantel; 2-(Cyclohexylcarbonyl)-1,2,3,6,7-11 b-hexahydro-4 H-pyrazino[2,1-a]isoquinolin-4-one |
Type | Certified Reference Material |
Quantity | 1 g |
Formula Weight | 312.41 |
Grade | Certified Reference Material |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction